Kiyoki Kitagawa

2.4k total citations
35 papers, 1.5k citations indexed

About

Kiyoki Kitagawa is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Kiyoki Kitagawa has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Nephrology, 13 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Kiyoki Kitagawa's work include Chronic Kidney Disease and Diabetes (11 papers), Renal Diseases and Glomerulopathies (11 papers) and Vasculitis and related conditions (8 papers). Kiyoki Kitagawa is often cited by papers focused on Chronic Kidney Disease and Diabetes (11 papers), Renal Diseases and Glomerulopathies (11 papers) and Vasculitis and related conditions (8 papers). Kiyoki Kitagawa collaborates with scholars based in Japan, United States and China. Kiyoki Kitagawa's co-authors include Kengo Furuichi, Takashi Wada, Hitoshi Yokoyama, Yasunori Iwata, Kouji Matsushima, Naofumi Mukaida, Norihiko Sakai, Yoshiro Ishiwata, Hiroyuki Hashimoto and Akinori Hara and has published in prestigious journals such as PLoS ONE, Diabetes Care and Kidney International.

In The Last Decade

Kiyoki Kitagawa

33 papers receiving 1.5k citations

Peers

Countries citing papers authored by Kiyoki Kitagawa

Since Specialization

Citations

This map shows the geographic impact of Kiyoki Kitagawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiyoki Kitagawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiyoki Kitagawa more than expected).

Fields of papers citing papers by Kiyoki Kitagawa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiyoki Kitagawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiyoki Kitagawa. The network helps show where Kiyoki Kitagawa may publish in the future.

Co-authorship network of co-authors of Kiyoki Kitagawa

This figure shows the co-authorship network connecting the top 25 collaborators of Kiyoki Kitagawa. A scholar is included among the top collaborators of Kiyoki Kitagawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiyoki Kitagawa. Kiyoki Kitagawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A case of acute lithium poisoning and hypermagnesemia involving advanced colon cancer-induced colonic obstruction 2024 ·Oxford Medical Case Reports ·Hideo Takayama, Takuya Komura, (unknown), (unknown), Makiko Kimura, Masashi Nishikawa, Kiyoki Kitagawa, Wataru Omi, Kenichi Sakajiri, Ichiro Onishi, Satoru Sakagami, Taro Yamashita, Takashi Kagaya	0
2	Age differences in the relationships between risk factors and loss of kidney function: a general population cohort study 2020 ·BMC Nephrology ·Tadashi Toyama, Kiyoki Kitagawa, Megumi Oshima, Shinji Kitajima, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, (unknown), Kengo Furuichi, Takashi Wada	25
3	Relationship between autoantibodies to erythropoietin receptor and renal outcome in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis 2020 ·Biomarkers ·Trang Thi Thu Tran, Akinori Hara, Kiyoki Kitagawa, Shinji Kitajima, Tadashi Toyama, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Shuichi Kaneko, Kengo Furuichi, Takashi Wada	1
4	Association between Unhealthy Dietary Habits and Proteinuria Onset in a Japanese General Population: A Retrospective Cohort Study 2020 ·Nutrients ·(unknown), Tadashi Toyama, Akinori Hara, Kiyoki Kitagawa, Yuta Yamamura, Shiori Nakagawa, Megumi Oshima, Taro Miyagawa, Kōichi Sato, Hisayuki Ogura, Shinji Kitajima, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Kengo Furuichi, (unknown), Takashi Wada	7
5	Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetes patients with diabetic nephropathy 2018 ·Journal of Diabetes Investigation ·Miho Shimizu, Kengo Furuichi, Tadashi Toyama, (unknown), Shinji Kitajima, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Toshinari Takamura, Kiyoki Kitagawa, Mitsuhiro Yoshimura, Shuichi Kaneko, Hitoshi Yokoyama, Takashi Wada, (unknown)	8
6	Value of adding the renal pathological score to the kidney failure risk equation in advanced diabetic nephropathy 2018 ·PLoS ONE ·Masayuki Yamanouchi, Junichi Hoshino, Yoshifumi Ubara, Kenmei Takaichi, Keiichi Kinowaki, Takeshi Fujii, Kenichi Ohashi, Koki Mise, Tadashi Toyama, Akinori Hara, Kiyoki Kitagawa, Miho Shimizu, Kengo Furuichi, Takashi Wada	19
7	Evidence-based clinical practice guidelines for rapidly progressive glomerulonephritis 2014 2016 ·Clinical and Experimental Nephrology ·Yoshihiro Arimura, Eri Muso, Shoichi Fujimoto, Midori Hasegawa, Shinya Kaname, Joichi Usui, (unknown), Masaki Kobayashi, Mitsuyo Itabashi, Kiyoki Kitagawa, Junichi Hirahashi, Kenjiro Kimura, Seiichi Matsuo	38
8	Risk factors associated with relapse or infectious complications in Japanese patients with microscopic polyangiitis 2015 ·Clinical and Experimental Nephrology ·(unknown), Kiyoki Kitagawa, Kengo Furuichi, Akihiro Sagara, Yasuyuki Shinozaki, Shinji Kitajima, Tadashi Toyama, Akinori Hara, Yasunori Iwata, Norihiko Sakai, Miho Shimizu, Shuichi Kaneko, Takashi Wada	20
9	Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats 2011 ·Nephrology Dialysis Transplantation ·Kengo Furuichi, Yukimasa Hisada, Miho Shimizu, Tomoko Okumura, Kiyoki Kitagawa, (unknown), Yasunori Iwata, Hitoshi Yokoyama, Shuichi Kaneko, Takashi Wada	22
10	Involvement of CD11b+ GR-1low cells in autoimmune disorder in MRL-Fas lpr mouse 2010 ·Clinical and Experimental Nephrology ·Yasunori Iwata, Kengo Furuichi, Kiyoki Kitagawa, Akinori Hara, Toshiya Okumura, Satoshi Kokubo, Kazuaki Shimizu, Norihiko Sakai, Akihiro Sagara, (unknown), Satoshi Ueha, Kouji Matsushima, Shuichi Kaneko, Takashi Wada	41
11	A case of neurosarcoidosis with necrotizing granuloma expressing angiotensin-converting enzyme 2010 ·Modern Rheumatology ·Shinji Kitajima, Norihiko Sakai, Kengo Furuichi, (unknown), Akinori Hara, Kiyoki Kitagawa, S Kitamura, Yoh Zen, Mitsutoshi Nakada, Shuichi Kaneko, Takashi Wada	3
12	Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti‐erythropoietin autoantibodies 2008 ·American Journal of Hematology ·Akinori Hara, Takashi Wada, Shinji Kitajima, Tadashi Toyama, Toshiya Okumura, Kiyoki Kitagawa, Yasunori Iwata, Norihiko Sakai, Kengo Furuichi, M. Higuchi, Shuichi Kaneko	30
13	Blockade of IP-10/CXCR3 Promotes Progressive Renal Fibrosis 2007 ·Nephron Experimental Nephrology ·Izaya Nakaya, Takashi Wada, Kengo Furuichi, Norihiko Sakai, Kiyoki Kitagawa, Hitoshi Yokoyama, Yuko Ishida, Toshikazu Kondo, Takeshi Sugaya, Hiroshi Kawachi, Fujio Shimizu, Shosaku Narumi, Makoto Haino, Craig Gérard, Kouji Matsushima, Shuichi Kaneko	38
14	Reduction in Chronic Allograft Nephropathy by Inhibition of p38 Mitogen-Activated Protein Kinase 2006 ·American Journal of Nephrology ·Takashi Wada, Haruhito Azuma, Kengo Furuichi, Norihiko Sakai, Kiyoki Kitagawa, Yasunori Iwata, Kouji Matsushima, Shiro Takahara, Hitoshi Yokoyama, Shuichi Kaneko	22
15	Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy 2005 ·American Journal of Kidney Diseases ·Norihiko Sakai, Takashi Wada, Kengo Furuichi, Yasunori Iwata, Keiichi Yoshimoto, Kiyoki Kitagawa, Satoshi Kokubo, Motoo Kobayashi, Akinori Hara, Junya Yamahana, Toshiya Okumura, Kazuya Takasawa, Shin’ichi Takeda, Mitsuhiro Yoshimura, Hiroshi Kida, Hitoshi Yokoyama	135
16	Blockade of CCR2 Ameliorates Progressive Fibrosis in Kidney 2004 ·American Journal Of Pathology ·Kiyoki Kitagawa, Takashi Wada, Kengo Furuichi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Masahide Asano, Motohiro Takeya, William A. Kuziel, Kouji Matsushima, Naofumi Mukaida, Hitoshi Yokoyama	277
17	The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese 2004 ·Kidney International ·Hitoshi Yokoyama, Takashi Wada, Akinori Hara, Junya Yamahana, Izaya Nakaya, Motoo Kobayashi, Kiyoki Kitagawa, Satoshi Kokubo, Yasunori Iwata, Keiichi Yoshimoto, Kazuaki Shimizu, Norihiko Sakai, Kengo Furuichi	119
18	Gene Therapy via Blockade of Monocyte Chemoattractant Protein-1 for Renal Fibrosis 2004 ·Journal of the American Society of Nephrology ·Takashi Wada, Kengo Furuichi, Norihiko Sakai, Yasunori Iwata, Kiyoki Kitagawa, Yuko Ishida, Toshikazu Kondo, Hiroyuki Hashimoto, Yoshiro Ishiwata, Naofumi Mukaida, Naohisa Tomosugi, Kouji Matsushima, Kensuke Egashira, Hitoshi Yokoyama	141
19	Gene Therapy Expressing Amino-Terminal Truncated Monocyte Chemoattractant Protein-1 Prevents Renal Ischemia-Reperfusion Injury 2003 ·Journal of the American Society of Nephrology ·Kengo Furuichi, Takashi Wada, Yasunori Iwata, Kiyoki Kitagawa, K. Kobayashi, Hiroyuki Hashimoto, Yoshiro Ishiwata, Naohisa Tomosugi, Naofumi Mukaida, Kouji Matsushima, Kensuke Egashira, Hitoshi Yokoyama	84
20	CCR2 Signaling Contributes to Ischemia-Reperfusion Injury in Kidney 2003 ·Journal of the American Society of Nephrology ·Kengo Furuichi, Takashi Wada, Yasunori Iwata, Kiyoki Kitagawa, (unknown), Hiroyuki Hashimoto, Yoshiro Ishiwata, Masahide Asano, Hui Wang, Kouji Matsushima, Motohiro Takeya, William A. Kuziel, Naofumi Mukaida, Hitoshi Yokoyama	203

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact